PHILADELPHIA and WHIPPANY, NEW JERSEY -- The American Association for Cancer Research (AACR) and Bayer HealthCare are pleased to announce a new partnership that will expand AACR's Basic Cancer Research Fellowship Program for 2015.
The AACR-Bayer HealthCare Basic Cancer Research Fellowships represent a joint effort to provide critical support to postdoctoral and clinical fellows conducting basic cancer research at the earliest stages of their careers. Two fellowships are being provided through this partnership.
"The AACR is excited to partner with Bayer to help young scientists develop their careers and to broaden our fundamental understanding of cancer through basic research," said Mitch Stoller, executive director of the AACR Foundation. "At the start of their careers, researchers are particularly vulnerable to the current funding crisis for biomedical research and the AACR is committed to supporting these young investigators whose discoveries will drive progress against the more than 200 diseases we call cancer."
The expansion of this program is significant, as it is one of the most highly competitive fellowships offered by AACR. Bayer's commitment to funding these additional fellowships will ensure that more talented young investigators have the necessary resources to explore their innovative research ideas.
"We are pleased to offer these two grants as part of our new partnership with the American Association for Cancer Research and support talented young investigators to explore their innovative approaches in basic cancer research and help increase understanding in tumor biology," said Karl Ziegelbauer, PhD, Head of Therapeutic Research Groups at Bayer HealthCare. "Our collaboration with the AACR underscores Bayer's continuous commitment to advancing research in the field of oncology."
The 2015 recipients of the AACR-Bayer HealthCare Basic Cancer Research Fellowships are Mario A. Shields, PhD, Cold Spring Harbor Laboratory in Cold Spring Harbor, New York, and Michelle P. Cicchini, PhD, the University of Pennsylvania in Philadelphia.
Each grant will provide $55,000 for one year, beginning July 1, 2015.
AACR and Bayer will continue their partnership in 2016, where two new fellowship opportunities will be available: the AACR-Bayer HealthCare Prostate Cancer Research Fellowship and the AACR-Bayer HealthCare Hepatocellular Carcinoma Research Fellowship.
The research proposed for funding may be basic, translational, clinical, or epidemiological in nature and must have direct applicability and relevance to either prostate cancer or hepatocellular carcinoma. These funding opportunities will be open to applications in the fall of 2015. All decisions regarding the review and selection of the submitted applications will be made by the AACR Scientific Review Committee in accordance with the policies and procedures of AACR.
###
Further details about the 2016 fellowships will be available online later this year. Additional inquiries may be directed to Ashley Jones at grants@aacr.org.
Follow the AACR: Cancer Research Catalyst http://blog.aacr.org; Twitter @AACR; and Facebook http://www.facebook.com/aacr.org
About the American Association for Cancer Research
Founded in 1907, the American Association for Cancer Research (AACR) is the world's oldest and largest professional organization dedicated to advancing cancer research and its mission to prevent and cure cancer. AACR membership includes more than 35,000 laboratory, translational, and clinical researchers; population scientists; other health care professionals; and cancer advocates residing in 101 countries. The AACR marshals the full spectrum of expertise of the cancer community to accelerate progress in the prevention, biology, diagnosis, and treatment of cancer by annually convening more than 25 conferences and educational workshops, the largest of which is the AACR Annual Meeting with almost 19,300 attendees. In addition, the AACR publishes eight prestigious, peer-reviewed scientific journals and a magazine for cancer survivors, patients, and their caregivers. The AACR funds meritorious research directly as well as in cooperation with numerous cancer organizations. As the Scientific Partner of Stand Up To Cancer, the AACR provides expert peer review, grants administration, and scientific oversight of team science and individual investigator grants in cancer research that have the potential for near-term patient benefit. The AACR actively communicates with legislators and other policymakers about the value of cancer research and related biomedical science in saving lives from cancer. For more information about the AACR, visit http://www.AACR.org.
About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of around EUR 20.0 billion (2014), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 60,700 employees (Dec 31, 2014) and is represented in more than 100 countries. More information is available at http://www.healthcare.bayer.com.